Atlas Trials

Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)

Clinical trial NCT04609098 · COMPLETED

Trial details

NCT number
NCT04609098
Sponsor
London School of Hygiene and Tropical Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malaria, Falciparum
Start date
2020-10-29
Primary completion
2020-12-02
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.